1
Managed Access Programs for LDK378, Ceritinib
Condition(s):Anaplastic Lymphoma Kinase (ALK)- Positive Tumors; Non-small Cell Lung Cancer (NSCLC)Last Updated:February 8, 2024Available
Include Studies Not Open or Pending
Condition(s):Anaplastic Lymphoma Kinase (ALK)- Positive Tumors; Non-small Cell Lung Cancer (NSCLC)Last Updated:February 8, 2024Available
Condition(s):ALK Positive MalignanciesLast Updated:February 28, 2024Recruiting
Condition(s):NeuroblastomaLast Updated:September 28, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.